Healthcare & Pharmaceuticals Industry Press Releases

MyoKardia Doses First Patient in Phase 3 VALOR-HCM Trial of Mavacamten

BRISBANE, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) announced that the first patient has been dosed in the Phase 3 VALOR-HCM clinical trial.  VALOR-HCM will enroll individuals with obstructive hypertrophic cardiomyopathy (HCM …

ChemoCentryx to Hold Second Quarter 2020 Financial Results Conference Call on Monday, August 10, 2020

MOUNTAIN VIEW, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's second quarter 2020 financial results will be released after market close on Monday, August 10, 2020. ChemoCentryx executive …

Intercept to Announce Second Quarter 2020 Financial Results on August 10, 2020

NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its …

TRACON Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference

SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted cancer therapeutics and utilizing a cost efficient, CRO- …

Coronavirus - Africa: COVID-19 ECOWAS Daily Update for August 2nd, 2020

Coronavirus - North East Nigeria: COVID-19 Situation Update (As at 1st August 2020)

Download logo The COVID-19 pandemic continues to gain infection traction in the North East states of Borno, Adamawa and Yobe, since the first index case was reported on the 18th of April 2020 in Borno State. With over 7.5 million people in need of …

Coronavirus - Libya: COVID-19 Update (3 August 2020)

Download logo Today, 146 COVID19 patients, 4 recoveries and 3 deaths have been reported by the NCDC in Libya. The updated total is 3837 patients; of whom 83 died and 623 recovered, while 3131patients are still being hospitalized.   Distributed by APO Group …

Coronavirus - Zambia: COVID-19 Daily Status Update (3rd August 2020)

233 new confirmed cases; 1 death; 208 recoveries New cases reported from: 148 Lusaka, 19 Mpika, 15 Kitwe, 9 Chirundu, 9 Senga Hill, 8 Luwingu, 7 Ndola, 6 Kasama, 6 Mufulira, 5 Chinsali, 1 Mungwi Death reported from: 1 Lusaka (Facility death) Recoveries …

Catalyst Pharmaceuticals to Hold Second Quarter 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday,...

CORAL GABLES, Fla., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, …

Celldex to Report Second Quarter 2020 Financial Results and Host Corporate Update Call

HAMPTON, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) will report second quarter 2020 financial results on Thursday, August 6, 2020 after the U.S. financial markets close. Celldex executives will host a conference call …

Chimerix to Report Second Quarter 2020 Financial Results and Provide an Operational Update on August 10, 2020

DURHAM, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that it will host a live conference call …

Akouos to Present at BTIG Virtual Biotechnology Conference

BOSTON, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene therapies for people worldwide who live with disabling hearing loss, today announced that Manny …

Neos Therapeutics to Host Second Quarter 2020 Financial and Operating Results Conference Call on August 10th, 2020

DALLAS and FORT WORTH, Texas, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that it will report its …

Rhythm Pharmaceuticals Reports Second Quarter 2020 Financial Results

-- Appointed David Meeker, M.D., as President and Chief Executive Officer – -- FDA granted rare pediatric disease designations for setmelanotide for the treatment of POMC and LEPR deficiency obesities -- -- Submitted MAA to EMA for setmelanotide in POMC …

Gritstone Oncology to Present at Two Upcoming Investor Conferences in August

EMERYVILLE, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced presentations at two …

eSolutions and Homecare Homebase Collaborate to Ease Reimbursement Challenges of Review Choice Demonstration

OVERLAND PARK, Kan., Aug. 03, 2020 (GLOBE NEWSWIRE) -- eSolutions Inc., a leading healthcare technology company, and Homecare Homebase (HCHB), the nation’s top software for home-based care, have collaborated to help home health agencies (HHAs) manage …

Cabaletta Bio to Present at Multiple August Investor Conferences

PHILADELPHIA, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases, today …

KidneyIntelX in Multi-Center Study to Monitor and Predict Kidney Risk in COVID-19 Patients

Surge in Chronic Kidney Disease and Kidney Failure Expected Post-COVID-19 Mount Sinai-Led Study to Assess 4,000 Surviving COVID-19 Patients NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Mount Sinai Health System and Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX …

PMV Pharma Closes $70 Million in Series D Financing

CRANBURY, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations, announced the completion of a $70 …

Yumanity Therapeutics Appoints Ellen K. Forest as Chief Human Resources Officer

CAMBRIDGE, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Yumanity Therapeutics, a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced the …